MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.940
+0.520
+11.76%
After Hours: 4.950 +0.01 +0.20% 19:56 09/21 EDT
OPEN
4.470
PREV CLOSE
4.420
HIGH
5.17
LOW
4.340
VOLUME
967.52K
TURNOVER
--
52 WEEK HIGH
14.98
52 WEEK LOW
3.960
MARKET CAP
62.52M
P/E (TTM)
-7.8914
1D
5D
1M
3M
1Y
5Y
Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wa...
GlobeNewswire · 09/07 20:04
Exoskeleton Market Size 2021 Explosive Factors of Revenue By Progression Status, Emerging Demands, Recent Trends, Business Opportunity, Share and Forecast To 2027
The Exoskeleton Market is segmented on the lines of its end-user, technology, Stationary Technology and regional. Based on end-user it covers HealthCare, Military and Industrial. Basis of Stationary Technology is segmented into active and passive. Based on...
Heraldkeepers · 09/06 12:23
Ekso Bionics Granted U.S. Patent Titled 'Human machine interfaces for lower extremity orthotics'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6672&f=G&l=50&d=PTXT&p=134&S1=20210824&OS=20210824&RS=20210824
Benzinga · 08/24 14:18
Ekso Bionics Granted European Patent Titled 'POWERED ORTHOTIC SYSTEM FOR COOPERATIVE OVERGROUND REHABILITATION'
https://data.epo.org/publication-server/pdf-document?pn=2968052&ki=B1&cc=EP
Benzinga · 08/11 13:53
Is Ekso Bionics Holdings (NASDAQ:EKSO) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Simply Wall St. · 08/09 06:48
Medical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast
The global medical robots market is likely to expand in the coming years due to advancements made in embedded systems. According to a report by Fortune Business Insights, titled "Medical Robots Market Size, Share and Global Trend By Product (Robotic System...
GlobeNewswire · 08/04 12:26
Ottobock hires Deutsche Bank, Goldman for 2022 listing -source
reuters.com · 08/03 19:50
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -4.00% and 3.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/29 22:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EKSO. Analyze the recent business situations of Ekso Bionics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EKSO stock price target is 11.00 with a high estimate of 11.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 72
Institutional Holdings: 4.74M
% Owned: 37.42%
Shares Outstanding: 12.66M
TypeInstitutionsShares
Increased
9
180.77K
New
4
45.41K
Decreased
7
155.55K
Sold Out
5
83.47K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.38%
Healthcare Equipment & Supplies
+0.22%
Key Executives
Chairman/Executive Director
Steven Sherman
President/Chief Executive Officer/Director
Jack Peurach
Chief Financial Officer/Secretary
John Glenn
Vice President
Jason Jones
Other
William Shaw
Independent Director
Mary Cloyd
Independent Director
Charles Li
Independent Director
Stanley Stern
Independent Director
Rhonda Wallen
No Data
  • All
  • Financials
  • Insiders
More
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates through two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells and rents exoskeletons for applications in the medical markets. Its leading product in EksoHealth, the EksoNR, is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment. EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Its products include EksoZeroG Arm and and EksoVest. EksoZeroG Arm is a mobile arm mount and EksoVest is an upper body exoskeleton.

Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.